These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 3183451

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-inflammatory drugs and the complement system. A condensation product of metacresolsulfonic acid and formaldehyde prevents instantly the complement activation in vitro.
    Gancevici GG, Popescu C.
    Arch Roum Pathol Exp Microbiol; 1989; 48(2):157-62. PubMed ID: 2634368
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Complement in vitro inhibition by a low-sulfate chondroitin sulfate (matrix).
    Biffoni M, Paroli E.
    Drugs Exp Clin Res; 1991; 17(1):35-9. PubMed ID: 1833171
    [Abstract] [Full Text] [Related]

  • 6. Action of a new non-steroid antiinflammatory drug, nimesulide, on activation of the complement system: an in vitro study.
    Auteri A, Saletti M, Blardi P, Di Perri T.
    Int J Tissue React; 1988; 10(4):217-21. PubMed ID: 3250936
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Extracts of airborne grain dusts activate alternative and classical complement pathways.
    Olenchock SA, Mull JC, Major PC.
    Ann Allergy; 1980 Jan; 44(1):23-8. PubMed ID: 6766283
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom.
    Bertazzi DT, de Assis-Pandochi AI, Talhaferro VL, Caleiro Seixas Azzolini AE, Pereira Crott LS, Arantes EC.
    Int Immunopharmacol; 2005 Jun; 5(6):1077-84. PubMed ID: 15829423
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L, Baenziger J, Pircher H, Hengartner H, Zinkernagel RM.
    J Immunol; 1986 Jun 15; 136(12):4674-80. PubMed ID: 3486908
    [Abstract] [Full Text] [Related]

  • 17. Protective effect of a purified flavonoid fraction against reactive oxygen radicals. In vivo and in vitro study.
    Lonchampt M, Guardiola B, Sicot N, Bertrand M, Perdrix L, Duhault J.
    Arzneimittelforschung; 1989 Aug 15; 39(8):882-5. PubMed ID: 2818676
    [Abstract] [Full Text] [Related]

  • 18. Intermediate and long-acting insulin preparations without protamine sulphate are complement activators in vitro.
    Duchateau J, Schreyen H, Dorchy H.
    Diabete Metab; 1992 Aug 15; 18(4):272-6. PubMed ID: 1459314
    [Abstract] [Full Text] [Related]

  • 19. Candidate inhibitors of porcine complement.
    Thorgersen EB, Ghebremariam YT, Thurman JM, Fung M, Nielsen EW, Holers VM, Kotwal GJ, Mollnes TE.
    Mol Immunol; 2007 Mar 15; 44(8):1827-34. PubMed ID: 17109963
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.